The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.
暂无分享,去创建一个
René Bernards | R. Bernards | T. Brummelkamp | A. D’Andrea | R. Kerkhoven | S. Nijman | A. Dirac | Tony T. Huang | Sebastian M B Nijman | Alan D D'Andrea | Tony T Huang | Annette M G Dirac | Ron M Kerkhoven | Thijn R Brummelkamp
[1] R. Bernards,et al. Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.
[2] Carlo Rago,et al. Tumour suppression: Disruption of HAUSP gene stabilizes p53 , 2004, Nature.
[3] S. Ganesan,et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.
[4] A. D’Andrea,et al. ATR couples FANCD2 monoubiquitination to the DNA-damage response. , 2004, Genes & development.
[5] C. Mathew,et al. Bi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia , 2003, British journal of haematology.
[6] Hans Joenje,et al. Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.
[7] Yuan-Tsong Chen,et al. A marker for Stevens–Johnson syndrome , 2004 .
[8] C. Chung,et al. Deubiquitinating enzymes as cellular regulators. , 2003, Journal of biochemistry.
[9] A. D’Andrea. The Fanconi road to cancer. , 2003, Genes & development.
[10] Susan M. Gordon,et al. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. , 2003, Blood.
[11] M. Loda,et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. , 2004, Cancer cell.
[12] D. Pellman,et al. Deubiquitinating enzymes: a new class of biological regulators. , 1998, Critical reviews in biochemistry and molecular biology.
[13] A. Auerbach,et al. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. , 1989 .
[14] C. Mathew,et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. , 2004, Blood.
[15] Weidong Wang,et al. A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome , 2003, Molecular and Cellular Biology.
[16] C. Mathew,et al. Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.
[17] C. Bishop,et al. A novel ubiquitin ligase is deficient in Fanconi anemia , 2003, Nature Genetics.
[18] S. H. Baek,et al. Deubiquitinating enzymes: their diversity and emerging roles. , 1999, Biochemical and biophysical research communications.
[19] H. Mohrenweiser,et al. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] K Tanaka,et al. Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. , 1998, Genomics.
[21] A. D’Andrea,et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. , 2002, Blood.
[22] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[23] K. Wilkinson. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. , 2000, Seminars in cell & developmental biology.
[24] Hans Joenje,et al. FANCE: the link between Fanconi anaemia complex assembly and activity , 2002, The EMBO journal.
[25] M. Yamaizumi,et al. Multiple roles of Rev3, the catalytic subunit of polζ in maintaining genome stability in vertebrates , 2003, The EMBO journal.
[26] K. J. Patel,et al. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. , 2004, Molecular cell.
[27] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[28] A. D’Andrea,et al. Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin , 2004, Molecular and Cellular Biology.
[29] G. Courtois,et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.
[30] René Bernards,et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.
[31] F. R. Papa,et al. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene , 1993, Nature.
[32] G. Pals,et al. X-linked inheritance of Fanconi anemia complementation group B , 2004, Nature Genetics.
[33] A. Ashworth,et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.
[34] Jennifer L. Harris,et al. Substrate profiling of deubiquitin hydrolases with a positional scanning library and mass spectrometry. , 2004, Biochemistry.
[35] C. Mathew,et al. Interaction of FANCD2 and NBS1 in the DNA damage response , 2002, Nature Cell Biology.
[36] R. Bernards,et al. Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage , 2000, Cell.
[37] Bo Xu,et al. Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways , 2002, Cell.
[38] J. Qin,et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.
[39] J. Pagano,et al. Tumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination , 2004, Molecular and Cellular Biology.
[40] Q. Waisfisz,et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. , 2000, Human molecular genetics.